PMC:7205724 / 3991-4180 JSONTXT 19 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T645 2-5 CD denotes 3.1
T646 7-16 NN denotes SARS-CoV2
T647 17-20 VBZ denotes has
T648 21-29 VBN denotes acquired
T649 30-32 DT denotes an
T650 33-34 NN denotes S
T651 35-47 NN denotes glycoprotein
T652 48-52 WDT denotes that
T653 53-59 RB denotes highly
T654 60-69 VBD denotes underwent
T655 70-77 JJ denotes genetic
T656 78-87 NN denotes variation
T657 88-91 CC denotes and
T658 92-105 NN denotes glycosylation
T659 107-112 CD denotes 3.1.1
T660 114-123 JJ denotes Polybasic
T661 124-132 NN denotes cleavage
T662 133-137 NN denotes site
T663 138-140 IN denotes As
T664 141-150 VBN denotes evidenced
T665 151-153 IN denotes by
T666 154-162 NN denotes sequence
T667 163-171 NN denotes analysis
T668 171-172 -COMMA- denotes ,
T669 173-178 EX denotes there
T670 179-181 VBZ denotes is
T671 182-183 DT denotes a
R639 T646 T645 arg1Of SARS-CoV2,3.1
R640 T646 T647 arg1Of SARS-CoV2,has
R641 T648 T647 arg2Of acquired,has
R642 T646 T648 arg1Of SARS-CoV2,acquired
R643 T651 T648 arg2Of glycoprotein,acquired
R644 T651 T649 arg1Of glycoprotein,an
R645 T651 T650 arg1Of glycoprotein,S
R646 T651 T652 arg1Of glycoprotein,that
R647 T654 T653 arg1Of underwent,highly
R648 T651 T654 arg1Of glycoprotein,underwent
R649 T657 T654 arg2Of and,underwent
R650 T657 T655 arg1Of and,genetic
R651 T656 T657 arg1Of variation,and
R652 T658 T657 arg2Of glycosylation,and
R653 T662 T659 arg1Of site,3.1.1
R654 T662 T660 arg1Of site,Polybasic
R655 T662 T661 arg1Of site,cleavage
R656 T670 T663 arg1Of is,As
R657 T664 T663 arg2Of evidenced,As
R658 T664 T665 arg1Of evidenced,by
R659 T667 T665 arg2Of analysis,by
R660 T667 T666 arg1Of analysis,sequence
R661 T670 T668 arg1Of is,","
R662 T669 T670 arg1Of there,is